Evaluation the effect of probiotics on gastrointestinal symptoms in patients with gastric cancer

Phase 2

Recruiting

• Conditions: Gasteric cancer.; Malignant neoplasm of stomach, unspecified; C16.9

• Registration Number: IRCT20211226053534N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age between 18 to 70 years
Endoscopically confirmed gastric cancer and pathology that are in the recovery phase (their treatment is over)
Refer to the gastroenterology clinic of Azad University of mashhad educational hospitals
Informed consent to enter the study

Exclusion Criteria

Obvious neurological disease
Probiotic consumption in the past month
Dissatisfaction with inclusion in the study
Lack of patient cooperation
Lack of proper use of the Probiotic in both groups
Sensitivity to the studied Probiotic
Pregnant or lactating women
Chronic users of non-steroidal anti-inflammatory drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS visual scale for Gastrointestinal symptoms such as abdominal pain, diarrhea, constipation and bloating. Timepoint: Before the intervention and at the end of the fourth and eighth weeks. Method of measurement: VAS visual scale.;. Timepoint: . Method of measurement: .